| Dr Chad O Patterson, MD | |
|
400 University Dr, Suite 203, Prestonsburg, KY 41653-1080 | |
| (606) 886-8183 | |
| (606) 886-0575 |
| Full Name | Dr Chad O Patterson |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 22 Years |
| Location | 400 University Dr, Prestonsburg, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023200920 | NPI | - | NPPES |
| 7100064520 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 41195 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Highlands Arh Regional Medical Center | Prestonsburg, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arh Tug Valley Health Services, Inc. | 4183953805 | 65 |
News Archive
Bruker unveiled the BioScope Resolve™, a biological atomic force microscope (bioAFM), at the sixth AFM BioMed Conference. The BioScope Resolve™ features excellent resolution imaging and comprehensive cell mechanics capabilities, and can be used with an inverted optical microscope (IOM).
A multidisciplinary team of Michigan State University researchers has been awarded $4.2 million to develop accurate clinical research tools for studying osteopathic manipulative medicine, a hands-on approach to the diagnosis and treatment of musculoskeletal disorders.
In this post in The Hill's "Congress Blog," Chris Collins, vice president and director of public policy for amfAR, The Foundation for AIDS Research, responds to a recently released analysis of adult mortality rates in African countries, which "found that between 2004 and 2008, in those nations where the President's Emergency Plan for AIDS Relief (PEPFAR) was most active, the odds of death were about 20 percent lower than in other countries in the region."
Xeltis, a privately held medical device company dedicated to transforming standards of care in heart valve replacement and vascular surgery, has announced that it has finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural, healthy heart valves and vessels. With its proprietary technology, the company has pioneered an entirely new therapeutic category called Endogenous Tissue Growth, or ETG, in which surgeons use unique implants designed to allow the body to repair itself by growing natural, healthy tissue.
› Verified 2 days ago
| Entity Name | Arh Tug Valley Health Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639949696 PECOS PAC ID: 4183953805 Enrollment ID: O20190905002344 |
News Archive
Bruker unveiled the BioScope Resolve™, a biological atomic force microscope (bioAFM), at the sixth AFM BioMed Conference. The BioScope Resolve™ features excellent resolution imaging and comprehensive cell mechanics capabilities, and can be used with an inverted optical microscope (IOM).
A multidisciplinary team of Michigan State University researchers has been awarded $4.2 million to develop accurate clinical research tools for studying osteopathic manipulative medicine, a hands-on approach to the diagnosis and treatment of musculoskeletal disorders.
In this post in The Hill's "Congress Blog," Chris Collins, vice president and director of public policy for amfAR, The Foundation for AIDS Research, responds to a recently released analysis of adult mortality rates in African countries, which "found that between 2004 and 2008, in those nations where the President's Emergency Plan for AIDS Relief (PEPFAR) was most active, the odds of death were about 20 percent lower than in other countries in the region."
Xeltis, a privately held medical device company dedicated to transforming standards of care in heart valve replacement and vascular surgery, has announced that it has finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural, healthy heart valves and vessels. With its proprietary technology, the company has pioneered an entirely new therapeutic category called Endogenous Tissue Growth, or ETG, in which surgeons use unique implants designed to allow the body to repair itself by growing natural, healthy tissue.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chad O Patterson, MD Po Box 406, Prestonsburg, KY 41653-0406 Ph: (606) 886-8183 | Dr Chad O Patterson, MD 400 University Dr, Suite 203, Prestonsburg, KY 41653-1080 Ph: (606) 886-8183 |
News Archive
Bruker unveiled the BioScope Resolve™, a biological atomic force microscope (bioAFM), at the sixth AFM BioMed Conference. The BioScope Resolve™ features excellent resolution imaging and comprehensive cell mechanics capabilities, and can be used with an inverted optical microscope (IOM).
A multidisciplinary team of Michigan State University researchers has been awarded $4.2 million to develop accurate clinical research tools for studying osteopathic manipulative medicine, a hands-on approach to the diagnosis and treatment of musculoskeletal disorders.
In this post in The Hill's "Congress Blog," Chris Collins, vice president and director of public policy for amfAR, The Foundation for AIDS Research, responds to a recently released analysis of adult mortality rates in African countries, which "found that between 2004 and 2008, in those nations where the President's Emergency Plan for AIDS Relief (PEPFAR) was most active, the odds of death were about 20 percent lower than in other countries in the region."
Xeltis, a privately held medical device company dedicated to transforming standards of care in heart valve replacement and vascular surgery, has announced that it has finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural, healthy heart valves and vessels. With its proprietary technology, the company has pioneered an entirely new therapeutic category called Endogenous Tissue Growth, or ETG, in which surgeons use unique implants designed to allow the body to repair itself by growing natural, healthy tissue.
› Verified 2 days ago
Troy Michael Sofinowski, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 5000 Ky Route 321 Ste 2162, Prestonsburg, KY 41653 Phone: 606-889-6185 Fax: 606-889-6186 | |
Dr. Syed G Badrudduja, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 400 University Dr Ste 203, Prestonsburg, KY 41653 Phone: 606-886-8183 Fax: 606-886-0575 | |
Dr. James H. Rothstein, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 5000 Ky Route 321, Prestonsburg, KY 41653 Phone: 606-886-1316 | |
Dr. Artour G Asrian, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 5000 Ky Route 321, Prestonsburg, KY 41653 Phone: 606-886-8511 | |
Jessica Lynn Marshall, D.O. Surgery Medicare: May Accept Medicare Assignments Practice Location: 400 University Dr Ste 212b, Prestonsburg, KY 41653 Phone: 606-886-8183 Fax: 606-886-0575 |